Polaryx Therapeutics
€1.6400
9
-€0.02-1.09% Friday 13:25
Statistics
Day High
1.626
Day Low
1.626
52W High
2.37
52W Low
1.524
Volume
-
Avg. Volume
-
Mkt Cap
81.75M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
2DecExpected
Q1 2026
Q2 2026
Next
-0.04
-0.03
-0.03
-0.02
Expected EPS
-0.040888
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-7.66MNet Income
Analyst Ratings
5.06Average Price Target
The highest estimate is 5.31.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 1V8.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small-molecule drug candidates designed to address core pathological mechanisms common to LSDs. The Company has one reportable segment: lysosomal storage disorders. The lysosomal storage disorders segment consists of the Company's costs associated with the preclinical and clinical development of the Company's product candidates.
Show more...
CEO
Alex Yang
Employees
11
Country
United States
ISIN
US73110F1003
WKN
000A4202Z
Listings
0 Comments
Share your thoughts
FAQ
What is Polaryx Therapeutics stock price today?▼
The current price of 1V8.F is €1.64 EUR — it has decreased by -1.09% in the past 24 hours. Watch Polaryx Therapeutics stock price performance more closely on the chart.
What is Polaryx Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Polaryx Therapeutics stocks are traded under the ticker 1V8.F.
What is Polaryx Therapeutics market cap?▼
Today Polaryx Therapeutics has the market capitalization of 81.75M
When is the next Polaryx Therapeutics earnings date?▼
Polaryx Therapeutics is going to release the next earnings report on December 02, 2026.
What is Polaryx Therapeutics revenue for the last year?▼
Polaryx Therapeutics revenue for the last year amounts to 0 EUR.
What is Polaryx Therapeutics net income for the last year?▼
1V8.F net income for the last year is -7.66M EUR.
How many employees does Polaryx Therapeutics have?▼
As of September 05, 2026, the company has 11 employees.
In which sector is Polaryx Therapeutics located?▼
Polaryx Therapeutics operates in the Health & Wellness sector.
When did Polaryx Therapeutics complete a stock split?▼
Polaryx Therapeutics has not had any recent stock splits.
Where is Polaryx Therapeutics headquartered?▼
Polaryx Therapeutics is headquartered in PARAMUS, United States.